Patent Yard Sign in
Canadian application, no grantCanada

Methods for inhibiting or suppressing stenosis of arteriovenous access fistulas and grafts

CA 2466833 A1 · Owner: Nielsen, Heidi · Inventors: Waters, Christina Ann; Nielsen, Heidi; Stephens, W. Patrick

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method for inhibiting or suppressing stenosis associated with an arteriovenous access. A dosage of photosensitive compound is introduced into the artery (14) or vein (12). An anastomotic area (16) of the artery (14) or vein (12) is then exposed to a source of light having a wavelength suitable for photoactivating the photosensitive compound for a period of time sufficient to provide a therapeutic effect. A method is also described for the delivery of drugs into the anastomotic site of an AV access to inhibit the formation of stenotic lesions at those sites.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 21, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 21, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 21, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 21, 2002
GrantedNo grant recorded
Term endedNovember 21, 2022
Patent numberCA 2466833 A1
Classification (IPC)A61N5/06 +1 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedNov 21, 2002Term endedNov 21, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.